Aura Biosciences, Inc.
Aura Biosciences, Inc. scores highest on Nitro (61) and lowest on Earnings (26). Its PosiPenta is 45.05 out of 100, around the middle of similar companies.
On the Penta Grid this week, Aura Biosciences, Inc. is Grid #381 of 837 in the Healthcare sector in United States, and Grid #2,411 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Aura Biosciences, Inc. | 45.05 | 29 | 26 | 61 | 52 | 57 |
| Achieve Life Sciences, Inc. | 34.91 | 0 | 50 | 78 | 14 | 33 |
| Solid Biosciences Inc. | 38.31 | 32 | 31 | 48 | 49 | 31 |
| Prime Medicine, Inc. | 39.49 | 48 | 41 | 52 | 8 | 49 |
| Lexicon Pharmaceuticals, Inc. | 41.25 | 17 | 44 | 56 | 45 | 44 |
| Attovia Therapeutics, Inc. | 36.71 | 0 | 28 | 38 | 62 | 55 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.49 |
| P/B ratio | 2.01 |
EEarnings
| Trailing EPS | ₹-165.75 |
| Forward EPS | ₹-192.27 |
NNitro
| Price | 577.76 |
| 52-week high | 903.11 |
| 52-week low | 448.00 |
| Fall from 52-week high | 36.0% |
TTorque
| Return on equity (ROE) | -53.48% |
| Debt-to-equity | 0.05 |
AAnchor
| Beta (price swings) | 0.41 |
| Market cap | ₹5,991 Cr |
| Insider holding | 2.43% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Aura Biosciences, Inc.'s PosiPenta score?
Aura Biosciences, Inc.'s PosiPenta is 45.05 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Aura Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Aura Biosciences, Inc. is Grid #381 of 837 in the Healthcare sector in United States, and Grid #2,411 of 4,000 in United States.
Which PosiPenta pillar is strongest for Aura Biosciences, Inc.?
Nitro (momentum), with a score of 61 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Aura Biosciences, Inc.?
Earnings (growth), with a score of 26 out of 100: weaker than most similar companies.
Has Aura Biosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.98 points, from 42.07 to 45.05.
PositoAI is for research and education only and is not investment advice.